The consequences of not renewing US FDA registration can be\nsignificant, depending on the type of facility that operates and the products they\nmanufacture. <\/p>\n\n\n\n
Food facilities:<\/p>\n\n\n\n
Expired registration: If your registration expires, the FDA\nwill consider it a violation of the Federal Food, Drug, and Cosmetic Act\n(FD&C Act). This can lead to:<\/p>\n\n\n\n
Warning letters: The FDA may issue a warning letter\noutlining the violation and requesting corrective action.<\/p>\n\n\n\n
Seizure of products: The FDA may seize the products if they\nbelieve that the products are manufactured in an unregistered facility or pose\na public health risk.<\/p>\n\n\n\n
Injunctions: The FDA may seek a court order to prevent from\ncontinuing to operate your facility until you come into compliance.<\/p>\n\n\n\n
Loss of business: Potential customers and suppliers may be\nhesitant to do business with a facility that is not in good standing with the\nFDA.<\/p>\n\n\n\n
Medical device establishments:<\/p>\n\n\n\n
Expired registration: Like food facilities, an expired\nregistration for a medical device establishment is a violation of the FD&C\nAct and can lead to:<\/p>\n\n\n\n
Warning letters: The FDA may issue a warning letter\noutlining the violation and requesting corrective action.<\/p>\n\n\n\n
Refusal to approve marketing applications: The FDA may\nrefuse to approve marketing applications for medical devices manufactured in\nunregistered establishments.<\/p>\n\n\n\n
Import restrictions: The FDA may restrict the import of\nmedical devices manufactured in unregistered establishments.<\/p>\n\n\n\n
Drugs<\/p>\n\n\n\n
Expired registration: Like other registration, an expired\nregistration for drug establishments is also violation of FDA&C Act and can\nlead to: <\/p>\n\n\n\n
Warning letters: The FDA may issue a warning letter\noutlining the violation and requesting corrective action.<\/p>\n\n\n\n
Refusal to approve marketing applications: The FDA may\nrefuse to approve marketing applications for drugs manufactured in unregistered\nestablishments. They will consider the drug as misbranded and de-activate all\nthe drugs listed FDA.<\/p>\n\n\n\n
Import restrictions: The FDA may restrict the import of\ndrugs manufactured in unregistered establishments. Also, they may seize the\nproducts if they believe they are manufactured in an unregistered facility or\npose a public health risk.<\/p>\n\n\n\n
Liberty Management Group<\/a>, as a renowned FDA consulting firm can help the companies in renewing the food establishment<\/a>, drug establishment<\/a> and medical device establishments<\/a> in a timely manner.<\/p>\n\n\n\n Sudha<\/p>\n\n\n\n Regulatory Consultant<\/p>\n\n\n\n Email: office@libertymanagement.us<\/p>\n\n\n\n www.fdahelp.us<\/a><\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" The consequences of not renewing US FDA registration can be significant, depending on the type of facility that operates and the products they manufacture. Food facilities: Expired registration: If your registration expires, the FDA will consider it a violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). This can lead to: Warning letters: … Continue reading “REGISTRATION DE-ACTIVATION”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[40,29],"class_list":["post-227","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-fda-drug-registration-renewal","tag-fda-medical-device-registration"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/comments?post=227"}],"version-history":[{"count":1,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/227\/revisions"}],"predecessor-version":[{"id":228,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/227\/revisions\/228"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/media?parent=227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/categories?post=227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/tags?post=227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}